You are here

BMS

‘No Time to Wait’ Ad Campaign from BMS-Pfizer Features Basketball Legend Kareem Abdul-Jabbar for AFib Awareness

Xtalks

Wed, 02/22/23 - 10:01 am

atrial fibrillation

celebrity endorsements

DTC advertising

SCAAR: Next-gen DES take the lead from BMS for lowest death risk

Thu, 01/19/12 - 10:55 pm

SPRYCEL® (dasatinib) Receives FDA Priority Review for the Treatment of Adult Patients with Newly Diagnosed Chronic Myeloid Leukemia (CML) in Chronic Phase

Yahoo/BusinessWire

Sat, 07/10/10 - 11:39 am

chronic myeloid leukemia

Barron's

Sat, 06/26/10 - 11:15 am

SPRYCEL(R) (dasatinib) Demonstrates Superior Confirmed Complete Cytogenetic Response Rates Compared to Gleevec(R)* in Study of Adult Patients with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase

BusinessWire

Sat, 06/5/10 - 12:24 pm

chronic myeloid leukemia